ES2039256T3 - Procedimiento para la obtencion de compuestos triciclicos. - Google Patents

Procedimiento para la obtencion de compuestos triciclicos.

Info

Publication number
ES2039256T3
ES2039256T3 ES198787401562T ES87401562T ES2039256T3 ES 2039256 T3 ES2039256 T3 ES 2039256T3 ES 198787401562 T ES198787401562 T ES 198787401562T ES 87401562 T ES87401562 T ES 87401562T ES 2039256 T3 ES2039256 T3 ES 2039256T3
Authority
ES
Spain
Prior art keywords
group
procedure
tricyclic compounds
vinylene
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787401562T
Other languages
English (en)
Inventor
Kathleen Biziere
Camille Georges Wermuth
Paul Worms
Jean-Jacques Bourguignon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2039256T3 publication Critical patent/ES2039256T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LOS NUEVOS DERIVADOS TRICICLICOS AGONISTAS DE RECEPTORES COLINERGICOS. ESTOS COMPUESTOS RESPONDEN A LA FORMULA (I) EN LA CUAL - X REPRESENTA UN GRUPO (CH2)N CON N REPRESENTANDO UN ENTERO IGUAL A 2,3 O 4 O DE NUEVO A UN GRUPO VINILENO O UN GRUPO METIL VINILENO; - R1 Y R2 CONSIDERADOS INDEPENDIENTEMENTE, REPRESENTAN AL HIDROGENO O UN SUSTITUYENTE QUE OCUPA UNA DE LAS POSICIONES LIBRES DEL CICLO BENCENICO Y ELEGIDO ENTRE LOS HALOGENOS, UN GRUPO ALQUILO INFERIOR, UN GRUPO ALCOXI INFERIOR, UN GRUPO HIDROXI, UN GRUPO TIOL, UN GRUPO NITRO, UN GRUPO AMINO EVENTUALMENTE SUSTITUIDO; - Y REPRESENTA EL OXIGENO, EL AZUFRE O UN GRUPO -NH-; - R3 REPRESENTA PRINCIPALMENTE UN GRUPO AMINO.
ES198787401562T 1986-07-03 1987-07-03 Procedimiento para la obtencion de compuestos triciclicos. Expired - Lifetime ES2039256T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609681A FR2601011B1 (fr) 1986-07-03 1986-07-03 Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant

Publications (1)

Publication Number Publication Date
ES2039256T3 true ES2039256T3 (es) 1993-09-16

Family

ID=9337042

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787401562T Expired - Lifetime ES2039256T3 (es) 1986-07-03 1987-07-03 Procedimiento para la obtencion de compuestos triciclicos.

Country Status (16)

Country Link
US (1) US4977152A (es)
EP (1) EP0251937B1 (es)
JP (1) JPH029866A (es)
KR (1) KR880001614A (es)
AR (1) AR245123A1 (es)
AT (1) ATE60589T1 (es)
AU (1) AU602339B2 (es)
CA (1) CA1312864C (es)
DE (1) DE3767794D1 (es)
DK (1) DK162220C (es)
ES (1) ES2039256T3 (es)
FR (1) FR2601011B1 (es)
GR (1) GR3001646T3 (es)
NZ (1) NZ220926A (es)
PT (1) PT85234B (es)
ZA (1) ZA874846B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
KR100422589B1 (ko) * 2001-11-20 2004-03-16 (주)경인양행 셀룰로오스 섬유 또는 셀룰로오스 혼방섬유의 염색 방법
ATE523199T1 (de) * 2004-11-02 2011-09-15 Univ Northwestern Pyridazinverbindungen und verfahren
EP1812408B1 (en) 2004-11-02 2013-10-09 Northwestern University Pyridazine compounds, compositions and methods
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
CA2650704A1 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
CA2650625A1 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
WO2009089305A1 (en) * 2008-01-07 2009-07-16 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2619818B1 (fr) * 1987-09-01 1990-01-12 Sanofi Sa Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
DK340987D0 (da) 1987-07-02
DK162220B (da) 1991-09-30
KR880001614A (ko) 1988-04-25
JPH029866A (ja) 1990-01-12
ATE60589T1 (de) 1991-02-15
PT85234B (pt) 1990-04-30
DK340987A (da) 1988-01-04
PT85234A (fr) 1987-08-01
CA1312864C (en) 1993-01-19
AU602339B2 (en) 1990-10-11
DE3767794D1 (de) 1991-03-07
DK162220C (da) 1992-03-02
AR245123A1 (es) 1993-12-30
AU7504987A (en) 1988-01-07
NZ220926A (en) 1989-11-28
ZA874846B (en) 1988-03-30
FR2601011A1 (fr) 1988-01-08
EP0251937B1 (fr) 1991-01-30
GR3001646T3 (en) 1992-11-23
FR2601011B1 (fr) 1988-10-28
US4977152A (en) 1990-12-11
EP0251937A1 (fr) 1988-01-07

Similar Documents

Publication Publication Date Title
ES2039256T3 (es) Procedimiento para la obtencion de compuestos triciclicos.
ES2059491T3 (es) Derivados de indol con anillos condensados.
ES2196344T3 (es) Derivados de sulfonamida y su uso en el tratamiento de trastornos de snc.
ES2175350T3 (es) Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
AR004655A1 (es) Un compuesto derivado de aminoacido, una composicion farmaceutica que lo contiene, un proceso para su sintesis y su uso para la fabricacion de un medicamento
PE20000339A1 (es) Biciclo [2.2.1] heptanos y compuestos relacionados
CO5690576A2 (es) Profarmacos de los inhibidores de bomba de protones
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
AR246300A1 (es) Composicion adaptada para ser reaccionada con peroxido de hidrogeno y metodo para producir luz quimioluminiscente azul con la misma.
ES2028865T3 (es) Procedimiento mejorado para la preparacion de derivados de macrolidas.
ES2136209T3 (es) Nuevos nitronilfenoles estericamente impedidos utiles como captadores de radicales libres.
ES2124219T3 (es) Agentes que proporcionan caracteristicas de deslizamiento.
ES2054725T3 (es) Heteroaromatos anulares de cinco miembros de p-fenoxi-fenoximetilo.
CO4900071A1 (es) Derivados de pirido [4´, 3´:4,5] tieno (2,3- d) pirimidina sustituidos en posicion 3
ES2009720A4 (es) Agentes para tenir los cabellos.
ES2091236T3 (es) Composiciones de lubricantes.
ES2129248T3 (es) Resolucion enantiomera de 4-(3,4-diclorofenil)-3,4-dihidro-1(2h)-naftalenona.
ES2081314T3 (es) Compuestos de diaminoetileno.
ES2162404T3 (es) Nuevos derivados del indol y del indazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2084792T3 (es) Derivados de hexahidroazepinas, un procedimiento para su preparacion y composiciones.
ES2054811T3 (es) Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2.
ES2060592T3 (es) Un tioester y su uso en la preparacion de composiciones farmaceuticas para el tratamiento de los sindromes de isquemia y reperfusion.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2052852T3 (es) Colorantes directos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251937

Country of ref document: ES